PAVmed Inc. (PAVM)’s financial ratios: A comprehensive overview

After finishing at $0.43 in the prior trading day, PAVmed Inc. (NASDAQ: PAVM) closed at $0.41, down -4.42%. In other words, the price has decreased by -$0.0190 from its previous closing price. On the day, 542467 shares were traded. PAVM stock price reached its highest trading level at $0.4525 during the session, while it also had its lowest trading level at $0.4110.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



Our goal is to gain a better understanding of PAVM by taking a closer look at its different ratios.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 07 when Glennon Michael J bought 100,000 shares for $0.62 per share. The transaction valued at 62,320 led to the insider holds 250,000 shares of the business.

Glennon Michael J bought 88,000 shares of PAVM for $56,082 on Dec 06. The Director now owns 150,000 shares after completing the transaction at $0.64 per share. On Dec 05, another insider, Glennon Michael J, who serves as the Director of the company, bought 62,000 shares for $0.69 each. As a result, the insider paid 42,606 and bolstered with 62,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PAVM now has a Market Capitalization of 44.05M and an Enterprise Value of 43.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 71.25. Its current Enterprise Value per Revenue stands at 68.83 whereas that against EBITDA is -0.43.

Stock Price History:

Over the past 52 weeks, PAVM has reached a high of $2.34, while it has fallen to a 52-week low of $0.35. The 50-Day Moving Average of the stock is 0.4428, while the 200-Day Moving Average is calculated to be 0.7456.

Shares Statistics:

The stock has traded on average 425.06K shares per day over the past 3-months and 525.93k shares per day over the last 10 days, according to various share statistics. A total of 97.09M shares are outstanding, with a floating share count of 83.40M. Insiders hold about 0.30% of the company’s shares, while institutions hold 13.70% stake in the company. Shares short for PAVM as of Apr 27, 2023 were 5.15M with a Short Ratio of 5.15M, compared to 5.57M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.23% and a Short% of Float of 5.63%.

Earnings Estimates

Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.16 and a low estimate of -$0.21, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.13 and low estimates of -$0.2.

Analysts are recommending an EPS of between -$0.6 and -$1 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.6, with 3 analysts recommending between -$0.49 and -$0.66.

Revenue Estimates

A total of 4 analysts have provided revenue estimates for PAVM’s current fiscal year. The highest revenue estimate was $8.5M, while the lowest revenue estimate was $1.8M, resulting in an average revenue estimate of $4.31M. In the same quarter a year ago, actual revenue was $377k, up 1,043.20% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $11.51M in the next fiscal year. The high estimate is $19.4M and the low estimate is $4.6M. The average revenue growth estimate for next year is up 167.10% from the average revenue estimate for this year.